DEFIBRILLATOR WILL BE SOLD EXCLUSIVELY BY GE HEALTHCARE WORLDWIDE
Cardiac Science Corporation, a global leader in advanced cardiac monitoring
and defibrillation products, announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) regulatory clearance to
market a new 'crash cart' defibrillator-monitor designed specifically for use
by medical professionals to respond to cardiac emergencies in hospital settings.
The new defibrillator will be sold exclusively by GE Healthcare (GE), a division
of General Electric Company in accordance with previously concluded agreements.